{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T10:31:53Z","timestamp":1793442713617,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jconrel.2026.115418","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:18:14Z","timestamp":1790608694000},"page":"115418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PB","title":["Protein expression kinetics of mRNA, saRNA, and pDNA as individual or co-delivered payloads using a common lipid nanoparticle formulation"],"prefix":"10.1016","volume":"399","author":[{"given":"Caitlin","family":"McMillan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muattaz","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Punnabhum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Varley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen Y.S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Rattray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Druschitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Perrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.jconrel.2026.115418_bb0005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"36","key":"10.1016\/j.jconrel.2026.115418_bb0010","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"14","key":"10.1016\/j.jconrel.2026.115418_bb0015","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.7150\/thno.77350","article-title":"Circular RNA cancer vaccines drive immunity in hard-to-treat malignancies","volume":"12","author":"Li","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.115418_bb0020","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.2147\/IJN.S366962","article-title":"Ionizable lipid nanoparticle-mediated delivery of plasmid DNA in cardiomyocytes","volume":"17","author":"Scalzo","year":"2022","journal-title":"Int. J. Nanomedicine"},{"issue":"47","key":"10.1016\/j.jconrel.2026.115418_bb0025","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9450","article-title":"CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy","volume":"6","author":"Rosenblum","year":"2020","journal-title":"Sci. Adv."},{"issue":"11","key":"10.1016\/j.jconrel.2026.115418_bb0030","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/mt.2008.200","article-title":"Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability","volume":"16","author":"Kariko","year":"2008","journal-title":"Mol. Ther."},{"issue":"5663","key":"10.1016\/j.jconrel.2026.115418_bb0035","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115418_bb0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.jconrel.2026.115418_bb0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.115418_bb0050","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jconrel.2024.08.016","article-title":"The role of helper lipids in optimising nanoparticle formulations of self-amplifying RNA","volume":"374","author":"Barbieri","year":"2024","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.jconrel.2026.115418_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010885","article-title":"Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines","volume":"18","author":"Elliott","year":"2022","journal-title":"PLoS Pathog."},{"issue":"10","key":"10.1016\/j.jconrel.2026.115418_bb0060","article-title":"A lipid nanoparticle-formulated self-amplifying RNA rift valley fever vaccine induces a robust humoral immune response in mice","volume":"12","author":"Kitandwe","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115418_bb0065","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1016\/j.ymthe.2025.03.060","article-title":"The advent of clinical self-amplifying RNA vaccines","volume":"33","author":"Casmil","year":"2025","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.jconrel.2026.115418_bb0070","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.cell.2024.03.018","article-title":"Self-amplifying RNA COVID-19 vaccine","volume":"187","author":"Wayne","year":"2024","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115418_bb0075","article-title":"DNA vaccines: their formulations, engineering and delivery","volume":"12","author":"Kozak","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115418_bb0080","doi-asserted-by":"crossref","first-page":"102025","DOI":"10.1016\/j.gendis.2025.102025","article-title":"DNA-based vaccines: advances, applications, and future prospects","author":"Zhou","year":"2026","journal-title":"Genes Dis."},{"issue":"9","key":"10.1016\/j.jconrel.2026.115418_bb0085","article-title":"Messenger RNA and plasmid DNA vaccines for the treatment of cancer","volume":"13","author":"Moseman","year":"2025","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115418_bb0090","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.nano.2016.12.014","article-title":"Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA","volume":"13","author":"Kulkarni","year":"2017","journal-title":"Nanomedicine"},{"issue":"4\u20136","key":"10.1016\/j.jconrel.2026.115418_bb0095","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000053993","article-title":"Plasmid DNA vaccines: investigation of integration into host cellular DNA following intramuscular injection in mice","volume":"43","author":"Ledwith","year":"2000","journal-title":"Intervirology"},{"issue":"3","key":"10.1016\/j.jconrel.2026.115418_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/vaccines1030225","article-title":"Vector design for improved DNA vaccine efficacy, safety and production","volume":"1","author":"Williams","year":"2013","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.jconrel.2026.115418_bb0105","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.jconrel.2026.115418_bb0110","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.2c00032","article-title":"Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach","volume":"19","author":"Ly","year":"2022","journal-title":"Mol. Pharm."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115418_bb0115","doi-asserted-by":"crossref","DOI":"10.1088\/2399-1984\/ad70e6","article-title":"The use of orthogonal analytical approaches to profile lipid nanoparticle physicochemical attributes","volume":"8","author":"Davidson","year":"2024","journal-title":"Nano Futures"},{"issue":"4","key":"10.1016\/j.jconrel.2026.115418_bb0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1039\/D4PM00128A","article-title":"Tailoring lipid nanoparticle dimensions through manufacturing processes","volume":"1","author":"McMillan","year":"2024","journal-title":"RSC Pharm."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115418_bb0125","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01066064","article-title":"A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation","volume":"6","author":"Yeh","year":"1978","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.jconrel.2026.115418_bb0130","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jconrel.2024.12.003","article-title":"Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine","volume":"378","author":"Lin","year":"2025","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.jconrel.2026.115418_bb0135","article-title":"Impact of B18R-encoding messenger ribonucleic acid co-delivery on neutralizing antibody production in self-amplifying messenger ribonucleic acid vaccines","volume":"13","author":"Wang","year":"2025","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.jconrel.2026.115418_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2024.07.078","article-title":"Delivery vehicle and route of administration influences self-amplifying RNA biodistribution, expression kinetics, and reactogenicity","volume":"374","author":"Bathula","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.jconrel.2026.115418_bb0145","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1038\/s41467-025-57149-2","article-title":"LNP-RNA-mediated antigen presentation leverages SARS-CoV-2-specific immunity for cancer treatment","volume":"16","author":"Xue","year":"2025","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115418_bb0150","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/jgm.178","article-title":"Time course of gene expression after plasmid DNA gene transfer to the liver","volume":"3","author":"Herweijer","year":"2001","journal-title":"J. Gene Med."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115418_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41587-025-02556-5","article-title":"Safer non-viral DNA delivery using lipid nanoparticles loaded with endogenous anti-inflammatory lipids","volume":"44","author":"Patel","year":"2026","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.115418_bb0160","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.115418_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1083191","article-title":"Beyond energy balance regulation: the underestimated role of adipose tissues in host defense against pathogens","volume":"14","author":"Barthelemy","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.jconrel.2026.115418_bb0170","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.cmet.2017.12.004","article-title":"An adipose tissue atlas: an image-guided identification of human-like BAT and beige depots in rodents","volume":"27","author":"Zhang","year":"2018","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.jconrel.2026.115418_bb0175","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ymthe.2020.11.011","article-title":"Innate inhibiting proteins enhance expression and immunogenicity of self-amplifying RNA","volume":"29","author":"Blakney","year":"2021","journal-title":"Mol. Ther."},{"issue":"37","key":"10.1016\/j.jconrel.2026.115418_bb0180","doi-asserted-by":"crossref","first-page":"33387","DOI":"10.1021\/acsnano.5c09956","article-title":"A machine learning assisted tool and numerical model for analyzing lipid nanoparticles","volume":"19","author":"Ip","year":"2025","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.jconrel.2026.115418_bb0185","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2311700120","article-title":"Lipid shape and packing are key for optimal design of pH-sensitive mRNA lipid nanoparticles","volume":"121","author":"Tesei","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.jconrel.2026.115418_bb0190","doi-asserted-by":"crossref","first-page":"7383","DOI":"10.1021\/acs.molpharmaceut.5c00614","article-title":"The use of enhanced analytical pipelines for the characterization of Poly(A) and Poly(A)-LNP formulation critical quality attributes","volume":"22","author":"Davidson","year":"2025","journal-title":"Mol. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926008229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T09:50:01Z","timestamp":1793440201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926008229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":38,"alternative-id":["S0168365926008229"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115418","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein expression kinetics of mRNA, saRNA, and pDNA as individual or co-delivered payloads using a common lipid nanoparticle formulation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.115418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115418"}}